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Background: the mean age of patients in the European Carotid Surgery Trial with greater than 70% stenosis was 62 years.
With changing demographics older patients are increasingly being referred for carotid endarterectomy (CEA).
Objectives: to assess the complications and survival (stroke-free and overall) of patients over the age of 75 undergoing
CEA.
Methods: analysis of a database, clinical records and cause of death of patients undergoing CEA in a single regional unit
over a 7 year period (1/4/1993 until 1/4/2000), with follow-up to April 2002. The rates of further neurological events were
obtained from the Scottish Morbidity Record 1 (SMR 1) of hospital discharges. Patients referred from outside the region
were excluded. Differences between groups were assessed by the Chi-squared test, with Yates correction and log-rank tests.
Results: of the 235 patients undergoing CEAs, 55 (23%) were 75 years or older. The post-operative neurological
complication rate was 1.7% in the under 75's and 5.4% in the older group (p5 0.05). The 30 day mortality was 1.1%
(two patients) and 1.8% (one patient) respectively. The Kaplan±Meier estimated survival for the under 75's and older were
93 and 75% at 3 years and 80 and 59% at 5 years respectively (p5 0.001). The Kaplan±Meier estimated neurological
event-free 5 year survival for the under 75's and older patients were 96 and 82% respectively (p5 0.001).
Conclusion: CEA in patients aged 75 years and over is associated with a significantly increased risk of stroke and death.
CEA may not benefit elderly patients with a reduced life expectancy.
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In 1991, the European (ECST) and North American
(NASCET) symptomatic carotid trials demonstrated
that carotid endarterectomy (CEA) was the treatment
of choice in patients with high grade (470%) symp-
tomatic stenosis.1,2 With changes in population life
expectancy, increasing numbers of elderly patients
are being referred and considered for CEA. The
mean age of patients with significant stenosis in the
ECST was 62.2 years. The value of CEA is largely
dependent on the complication rate of the procedure
and it is unclear if the risks are increased in the elderly
population. This is particularly relevant as over half
of strokes occur in patients older than 75 years.3
Pemberton et al. have shown that CEA can be per-
formed safely in selected patients older than 70 years.4
Further studies also suggest that patients should not
be denied CEA on the basis of age alone and resultsPlease address all correspondence to: J. Brittenden, Department of
Vascular Surgery, Ward 36, Aberdeen Royal Infirmary, Foresterhill,
Aberdeen AB25 2ZN, Scotland, UK.
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However, overall survival is known to be reduced and
in addition peri-operative mortality has been shown
to be increased in octogenarians.9 A meta-analysis of
the ECST data has shown that age 75 and over was
associated with an increased risk of peri-operative
stroke following CEA.10 Since the publication of both
ECST and NASCET, improvements in outcome have
been observed by many groups which have been
attributed to improved technique.11±14 It is unclear if
these improvements have also occurred in the increas-
ing number of older patients now undergoing CEA.
The aim of this study was to assess the complications,
stroke-free and overall survival in patients under-
going CEA in those aged 75 and over compared to
those aged less than 75 years.
Patients and Methods
We analysed the prospectively collected carotid data-
base of all CEAs performed in the Aberdeen Vascularrights reserved.
Table 1. Presenting symptoms, risk factors and co-morbidity in
patients aged 75 years or older compared to younger than 75.
Less than 75 years
n 180 (%)
75 years or
older n 55 (%)
Presenting symptoms
Asymptomatic 7 (4) 1 (2)
Amaurosis Fugax 50 (28) 14 (25)
Retinal artery occlusion 3 (2) 3 (5)
Transient ischaemic attack 95 (53) 24 (43)
Stroke with full recovery 35 (19) 14 (25)
Stroke with residual defecit 20 (11) 4 (7)
Risk and co-morbidity factors
Established hypertension 94 (52) 39 (71)
Angina, myocardial infarct 59 (33) 25 (47)
Peripheral vascular disease 51 (28) 18 (33)
Diabetes 32 (18) 19 (35) y
History of smoking 158 (88) 42 (76)
No antiplatelet therapy (7) 6 (11)
 p5 0.05, y p 0.008.
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1st April 2000. Follow-up was continued until April
2002, thus ensuring a minimal follow-up of 24 months.
The vascular unit referral area comprises the
Grampian, Highland, Orkney & Shetland health
board areas and serves a population of 773 920. In
this analysis we have not included patients from the
Highlands and Islands who also undergo CEA in our
unit as we do not have comparable figures for the
rates of hospital re-admissions with symptomatic
disease and accurate data regarding deaths. Patients
in Grampian represent a stable population which
facilitates accurate follow-up information. The rates
of further neurological events which involved an in
patient admission were obtained from the Scottish
Morbidity Record 1 (SMR 1) of hospital discharges
(ISD 9 codes 433.1, 433.09, 435, 437.1; ICD -10: 165.2,
163, 163.2, G45.1, G45.3, G45.9). The accuracy of SMR 1
data for main clinical diagnosis has previously been
shown to be 89%.8 In addition, the notes of all the
patients were assessed to determine if they had
a further neurological event which did not involve
a hospital admission. The timing and cause of death
of patients who had previously undergone CEA was
determined from the Grampian Regional Office death
files, and were cross-referenced with the date of birth,
postcode, surname and first name of the patients on
the carotid database.
Neurological complications lasting more than 24 h
were classified according to Rankin criteria as non-
disabling, disabling or fatal strokes.15 Pre-operative
risk factors and peri-operative outcome in patients
older than and less than 75 years were compared
using the Chi-squared test with Yates correction.
Logistical regression analysis was performed to deter-
mine if age 75 and over was an independent risk
factor. The effect of co-morbidity and presenting
symptoms on outcome were also evaluated by uni-
variate and multivariate analysis. Overall and stroke
free survival was assessed by Kaplan±Meier estimates
and log-rank analysis provided by SPSS 10.1.
Results
Two hundred and thirty-five patients underwent CEA
during the study time-period, of whom 55 (23%) were
older than 75 years. The number of patients aged 75
and over increased 3 fold from 1991 to 2000. The male
to female ratio was higher in the under 75's compared
to the older group: 2:1 and 1:1 respectively (p5 0.041).
The patients' presenting symptoms, risk factors
and co-morbidity are shown in Table 1. Increased co-
morbidity was present in the patients aged 75 andEur J Vasc Endovasc Surg Vol 26, September 2003over, particularly with regard to hypertension and
diabetes (p5 0.05). However, the older patients were
significantly less likely to be current smokers or to
have ever smoked.
Pre-operative brain CT scans were performed in 119
(67%) of patients younger than 75 and 26 (47%) of
those older. The percentage positive CT scans were
60 and 65% respectively. A contralateral internal
carotid artery stenosis of 70±99% was present in 16%
of each group. Contralateral occlusions were present
in 7% of the under 75's compared to 5% in the older
patients. The surgical technique was similar in both
groups. All procedures were performed under general
anaesthetic, shunts were used in 87% of the patients
aged less than 75 and 93% of those older, patch angio-
plasty were used in 45 and 52% respectively. The
decision whether to perform shunting or patch angio-
plasty was made by the individual consultant surgeon
based on patient characteristics. There was no unit
policy particularly with regards to patch angioplasty,
as one consultant routinely patched, one did so selec-
tively and another routinely performed primary clos-
ure. In a univariate and multivariate analysis, these
variables were found not to affect outcome.
Operative outcome (30 day)
The post-operative neurological event rate was 1.7%
and 5.4% (p5 0.005) in the under and over 75's
respectively. Age 75 and over was confirmed as an
independent risk factor on logistical regression anal-
ysis (p 0.028). Gender, the presence of peripheral
vascular disease, diabetes, and systolic hypertension
(4180 mmHg) were not independent risk factors.
With regards to presenting symptoms, only stroke
F/U 0 20 40 60 80 100
<75 178 175 131 72 28 4
>74 54 48 31 13 5
Fig. 1. The Kaplan±Meier estimated overall survival for the under
(narrow and lighter) and over 75's (broader and darker line)
(p5 0.001, Log rank analysis). The table shows the number of
remaining patients at the various timepoints.
Table 2. Cause of death in patients aged 75 years or older
compared to younger than 75 (excludes 30 day post-operative
mortality).
Less than 75 years
n 35 (%)
75 years or older
n 21 (%)
Cardiac related 20 (57) 9 (43)
Cancer 8 (23) 5 (24)
Respiratory 2 (6) 3 (14)
Sequelae of CVA 4 (11) 1 (5)
Other 1 (3) 3 (14)
Abbreviations: CVA ± Cerebrovascular accident.
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(p 0.036).
In the younger patients there were 3 post-operative
cerebrovascular accidents, all non-disabling (Rankin
grade 2). One CVA, due to internal carotid artery
thrombosis occurred within 36 h and was successfully
treated by thrombectomy. The other two occurred at
7 or more days following CEA, both had normal
duplex scans and CT revealed the cause of stroke to
be a watershed infarct and intracranial haemorrhage.
In the patients aged 75 and older there was one non-
disabling CVA (Rankin grade 2), one disabling
(Rankin grade 4), one fatal CVA and two transient
ischaemic attacks. The cause of the non-fatal strokes
were emboli and intracranial haemorrhage. The fatal
stroke and only post-operative death occurred in an
85-year-old female. The 30 day mortality in the under
75's was 1.1% (two patients) and 1.8% (one patient) in
the older group. The cause of death in the younger
patients was contralateral CVA at 1 week post CEA
and ruptured abdominal aortic aneurysm.
Long-term follow-up
The mean survival time for the younger and 75 and
over patients were 88 months (95% CI 83±92) and 62
months (95% CI 53±72) respectively.
In the younger age group there were 35 (20%)
deaths after the 30-day post-operative period. In the
75 and over age group there were 21 (39%) deaths
after the 30-day post-operative period. The Kaplan±
Meier estimated 3 and 5 year survival for the under 75
were 93, 75% and for the older patients were 80 and
59% respectively (p5 0.001, Fig. 1). Cardiaccauseswere
the major cause of death in both age groups (Table 2).
The Kaplan±Meier estimated neurological event-
free 5 year survival for the under and over 75's were
96 and 82% respectively (p5 0.001, Fig. 2). The major
stroke and neurological mortality rate was 4% (7) in
the younger age group and 10% (5) in the older age
group.
In the patients aged under 75 years, 11 neurological
events occurred after the 30 day post-operative per-
iod. Five were ipsilateral, these consisted of four TIAs
and one CVA and the remainder were contralateral.
The ipsilateral events occurred at the following
time intervals: 5, 7 11, 15, 38 and 44 months. The
CVA was due to ipsilateral cerebral metastases. All
the ipsilateral TIAs were investigated by duplex.
The findings for the ipsilateral carotid were: normal,
n 2; 61% stenosis, n 1, and 4 70% stenosis, n 1.
One female patient underwent a successful redo
CEA. The contralateral neurological events were allCVA ± one non-disabling (Rankin grade 2) and three
disabling (Rankin grade 3 & 4). Three patients died of
CVA, all were out of hospital deaths and it is unclear
what side the neurological event occurred. However
all three patients were known to have a contralateral
asymptomatic internal carotid stenosis of greater
than 80%.
There were seven further neurological events in the
patients aged 75 and older that occurred after the 30
day post-operative period. Two were ipsilateral non-
disabling strokes (Rankin grade 2) occurring at 30 and
38 months post-operatively. There were 5 contralateral
neurological events ± one TIA and four disabling
strokes (Rankin grades 3, n 2 and 4, n 2).
Wound haematomas occurred in five (3%) of
the patients aged under 75 and in five (9%) of those
aged 75 and over (p 0.042). These requiredEur J Vasc Endovasc Surg Vol 26, September 2003
F/U 0 20 40 60 80 100
<75 178 174 130 72 28 4
>74 47 31 13 5
Fig. 2. The Kaplan±Meier estimated neurological event-free sur-
vival for the under (narrow and lighter) and over 75's (broader
and darker line) (p5 0.001, Log rank analysis). The table shows
the number of remaining patients at the various timepoints.
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and in three (5%) patients in the older group
(p 0.014). Nerve damage was documented in 9 (5%)
of the patients under 75 and in two (4%) of those aged
75 and over (p 0.675). In the majority of cases this
was temporary, but long term follow-up data regard-
ing nerve damage was not recorded. Cardiac compli-
cations occurred in two (1%) patients in the younger
group and in five (9%) patients in the older group
(p 0.002).
Discussion
This study has shown that CEA in patients greater
than 75 years of age is associated with significantly
increased risk of stroke and death. Since the publica-
tion of both ECST and NASCET, improvements in
outcome have been observed by many groups.11±14 In
this study, the overall 30 day disabling stroke (Rankin
grade 3±5) and mortality rate for all patients under-
going CEA of 1.3% compares favorably with the rates
of 3.7% in the ECST and 3% in NASCET.1,2 This has
occurred without any obvious change in clinical tech-
nique. However, the disabling stroke and mortality
rate of 3.6% in patients aged 75 and older was more
than double that of the younger patients.
Since the publication of the large randomised trials
there has been a substantial increase in the number ofEur J Vasc Endovasc Surg Vol 26, September 2003elderly patients being referred for and undergoing
CEA. CEA in patients aged 80 and older has not
been assessed in a randomised controlled trial. The
final report of the ECST trial has concluded that the
decision to operate on patients with significant symp-
tomatic stenosis should be based on a statistical model
incorporating the precise degree of stenosis, age
and sex.16 Unfortunately the model was based on a
retrospective analysis of the data and only includes
patients aged 50±80 years.
Some studies have reported no increase in morbid-
ity or mortality in those patients aged 75 and older
undergoing CEA.5±7 However, Ting et al. have
reported a higher mortality in elderly patients under-
going CEA.9 There are several reasons other than pub-
lication bias which may account for the increased
morbidity identified in our study. Firstly, many of
the studies have included asymptomatic patients,
which in some cases account for up to 55% of the
elderly patients undergoing CEA. Such patients
which might be expected to have a better outcome
following CEA.5,8,17 In our study there was a signifi-
cantly increased number of females undergoing CEA
in the group aged 75 and over. A meta-analysis of the
ECST data has shown that the risk of developing a
peri-operative stroke is increased in women.10 How-
ever, other studies have not shown female gender to
be a risk factor and a meta-analysis of symptomatic
carotid trials has shown CEA to be equally beneficial
for males and females.18,19 The older patients in this
study also had an increased incidence of hypertension
and diabetes, although there is debate as to whether
these factors increase the risk of post-operative neuro-
logical events.10,18,20,21 It is of interest to note that as
observed in other studies the patients aged 75 and
over were less likely to have a history of smoking.17
In addition to the increased complication rate
observed in the patients aged 75 and over, the 5 year
Kaplan±Meier survival rate was significantly reduced.
There are several recent studies which have assessed
survival in the patients aged 80 and over but the
authors are only aware of three studies which have
assessed this in patients aged 75 and over.22±24 Five
year survival rates of 73 to 80% have been reported for
patients over 75 undergoing CEA. However these stu-
dies are difficult to intepret as they included asymp-
tomatic patients and partly predate the publication of
ECST and NASCET. These same studies reported
5 year stroke free survival rates of 68 to 90.9% in
patients ages 75 and older undergoing CEA. In this
study the 5 year neurological event-free survival in the
patients older than 75 was 80% and significantly
reduced compared to the younger patients. However,
it should be noted that many of the neurological
Accepted 24 March 2003
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have included TIAs as well as strokes.
In summary, we have found that patients under-
going CEA aged 75 or older have a significantly
increased risk of stroke and death. Patients aged 75
and older should be informed of the increased risks
and decreased benefits of surgical intervention.
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